Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Barbui

Showing results (51-60 of 380) with videos related to

Pageof 38
Sort By:
Thrombosis and Haemostasis|August 31, 1977
The aspirin tolerance test in von Willebrand's diseaseT Barbui, F Rodeghiero, E Dini
Haematologica|January 1, 1972
[Semiautomatic study of platelet aggregation]E Dini, T Barbui, R Battista
Schweizerische Medizinische Wochenschrift|September 28, 1974
[Methodological studies for the determination of protein 8 and of its biological activity]G Ballerini, T Barbui, F Scagliarini
Advances in Experimental Medicine and Biology|September 29, 1999
Apoptosis by anthracyclines at therapeutic concentrations in MDR1+ human leukemic cellsB Chiodini, R Bassan, T Barbui
British Journal of Haematology|June 1, 1994
Further characterization of platelet-aggregating cysteine proteinase activity in thrombotic thrombocytopenic purpuraR Consonni, A Falanga, T Barbui
Acta Haematologica|January 1, 1976
Two serum IgG-M components of different light-chain types in a case of Hodgkin's diseaseT Chisesi, T Barbui, G Capnist
American Journal of Hematology|November 1, 1991
In vivo efficacy of intravenous gammaglobulins in patients with lupus anticoagulant is not mediated by an anti-idiotypic mechanismM Galli, S Cortelazzo, T Barbui
European Journal of Cancer & Clinical Oncology|September 1, 1988
Therapeutic efficacy of danazol in myelodysplastic syndromesB Marini, R Bassan, T Barbui
Blood|April 16, 1998
Differential effects of anti-beta2-glycoprotein I and antiprothrombin antibodies on the anticoagulant activity of activated protein CM Galli, L Ruggeri, T Barbui
American Journal of Hematology|April 1, 1985
Interaction between a serum factor and T lymphocytes in Gaucher diseaseR Bassan, A Montanelli, T Barbui
Pageof 38

Showing results (51-60 of 380) with videos related to

Sort By:
Pageof 38
Thrombosis and Haemostasis|August 31, 1977
The aspirin tolerance test in von Willebrand's diseaseT Barbui, F Rodeghiero, E Dini
Haematologica|January 1, 1972
[Semiautomatic study of platelet aggregation]E Dini, T Barbui, R Battista
Schweizerische Medizinische Wochenschrift|September 28, 1974
[Methodological studies for the determination of protein 8 and of its biological activity]G Ballerini, T Barbui, F Scagliarini
Advances in Experimental Medicine and Biology|September 29, 1999
Apoptosis by anthracyclines at therapeutic concentrations in MDR1+ human leukemic cellsB Chiodini, R Bassan, T Barbui
British Journal of Haematology|June 1, 1994
Further characterization of platelet-aggregating cysteine proteinase activity in thrombotic thrombocytopenic purpuraR Consonni, A Falanga, T Barbui
Acta Haematologica|January 1, 1976
Two serum IgG-M components of different light-chain types in a case of Hodgkin's diseaseT Chisesi, T Barbui, G Capnist
American Journal of Hematology|November 1, 1991
In vivo efficacy of intravenous gammaglobulins in patients with lupus anticoagulant is not mediated by an anti-idiotypic mechanismM Galli, S Cortelazzo, T Barbui
European Journal of Cancer & Clinical Oncology|September 1, 1988
Therapeutic efficacy of danazol in myelodysplastic syndromesB Marini, R Bassan, T Barbui
Blood|April 16, 1998
Differential effects of anti-beta2-glycoprotein I and antiprothrombin antibodies on the anticoagulant activity of activated protein CM Galli, L Ruggeri, T Barbui
American Journal of Hematology|April 1, 1985
Interaction between a serum factor and T lymphocytes in Gaucher diseaseR Bassan, A Montanelli, T Barbui
Pageof 38